|
2000 Journal Article Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trialBarwood, S., Baillieu, C., Boyd, R., Brereton, K., Low, J., Nattrass, G. and Graham, H. K. (2000). Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Developmental Medicine and Child Neurology, 42 (2), 116-121. doi: 10.1111/j.1469-8749.2000.tb00056.x |
|
2000 Journal Article Recommendations for the use of botulinum toxin type A in the management of cerebral palsyGraham, H. K., Aoki, K. R., Autti-Ramo, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., Matthews, D., Molenaers, G., Motta, F., Ruiz, P. J. G. and Wissel, J. (2000). Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait and Posture, 11 (1), 67-79. doi: 10.1016/S0966-6362(99)00054-5 |
|
2000 Journal Article Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsyBoyd, R. N., Pliatsios, V., Starr, R., Wolfe, R. and Graham, H. K. (2000). Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Developmental Medicine and Child Neurology, 42 (1), 32-41. doi: 10.1111/j.1469-8749.2000.tb00022.x |
|
1999 Journal Article Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsyBoyd, R. N., Graham, J. E. A., Nattrass, G. R. and Graham, H. K. (1999). Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. European Journal of Neurology, 6 (S4), S37-S45. doi: 10.1111/j.1468-1331.1999.tb00033.x |
|
1999 Journal Article Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsyBoyd, R. N. and Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology, 6 (Suppl. 4), S23-S35. doi: 10.1111/j.1468-1331.1999.tb00031.x |
|
1999 Journal Article High- or low-technology measurements of energy expenditure in clinical gait analysis?Boyd, R., Fatone, S., Rodda, J., Olesch, C., Starr, R., Cullis, E., Gallagher, D., Carlin, J. B., Nattrass, G. R. and Graham, K. (1999). High- or low-technology measurements of energy expenditure in clinical gait analysis?. Developmental Medicine and Child Neurology, 41 (10), 676-682. doi: 10.1111/j.1469-8749.1999.tb00522.x |
|
1998 Conference Publication Biomechanical transformation of the gastrosoleus muscle by injection of botulinum toxin A in ambulant children with cerebral palsyBoyd, R., Pliatsios, V., Starr, R., Nattrass, G. and Graham, H. K. (1998). Biomechanical transformation of the gastrosoleus muscle by injection of botulinum toxin A in ambulant children with cerebral palsy. -, -, 1998. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0966-6362(98)90243-0 |
|
1997 Journal Article The hip in children with cerebral palsy: Predicting the outcome of soft tissue surgeryCornell, M. S., Hatrick, N. C., Boyd, R., Baird, G. and Spencer, J. D. (1997). The hip in children with cerebral palsy: Predicting the outcome of soft tissue surgery. Clinical Orthopaedics And Related Research, 340 (340), 165-171. |
|
1997 Conference Publication Biomechanical transformation of the gastrocnemius muscle by injection of Botulinum toxin A and casting in ambulant children with cerebral palsyBoyd, R. N., Pliatsios, V., Starr, R. and Graham, H. K. (1997). Biomechanical transformation of the gastrocnemius muscle by injection of Botulinum toxin A and casting in ambulant children with cerebral palsy. International Meeting of the European Society for Movement Analysis in Children, Basel, Switzerland, 13–15 November 1997. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0966-6362(97)90078-3 |
|
1997 Conference Publication Botulinum toxin A in the management of children with cerebral palsy: indications and outcomeBoyd, R. and Graham, H. K. (1997). Botulinum toxin A in the management of children with cerebral palsy: indications and outcome. 3rd European Botulinun Toxin Symposium, London, England, 28 February - 2 March 1997. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1997 Conference Publication Botulinum toxin in the management of children with cerebral palsy - Objective measurement of clinical findings and a management algorithmBoyd, R. N., Pliatsios, V. and Graham, H. K. (1997). Botulinum toxin in the management of children with cerebral palsy - Objective measurement of clinical findings and a management algorithm. International Meeting of the European Society for Movement Analysis in Children, Basel, Switzerland, 13-15 November 1997. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0966-6362(97)90084-9 |
|
1996 Journal Article Transient urinary incontinence after botulinum A toxinBoyd, RN, Britton, TC, Robinson, RO and Borzyskowski, M (1996). Transient urinary incontinence after botulinum A toxin. Lancet, 348 (9025), 481-482. doi: 10.1016/S0140-6736(05)64586-2 |
|
1994 Journal Article Imaging the acetabulum in children with cerebral palsyCornell, M. S., Boyd, R., Baird, G. and Spencer, J. D. (1994). Imaging the acetabulum in children with cerebral palsy. Journal of Bone and Joint Surgery: British Volume, 76B (6), 982-983. |
